ערך בספרים למניה: SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals (SXTC) is currently in a stagnation phase as its traditional medicine portfolio loses relevance. The business relies on the supply of generics to Chinese clinics and pharmacies, targeting the Asian healthcare market. The current indicator is 250416.74. The security price action shown below reflects volatility driven by stringent product quality oversight, low asset liquidity, and the threat of delisting.

This indicator determines the actual liquidation value of a single share package by subtracting total liabilities from the company's total assets. By analyzing the book value per share metric for China SXT Pharmaceuticals (SXTC), an investor can see the business foundation, the stability of which is constrained by low margins and a dependence on the cost of plant-based raw materials within a mature market.